Quick Takeaways
- Forbion Growth Opportunities Fund III Cooperatief U.A. filed SCHEDULE 13G for MapLight Therapeutics, Inc. Voting Common Stock, par value $0.0001 per share (MPLT).
- Disclosed ownership: 7.1%.
- Date of event: 31 Dec 2025.
Forbion Growth Opportunities Fund III Cooperatief U.A. - 31 Dec 2025 SCHEDULE 13G Report for MapLight Therapeutics, Inc. Voting Common Stock, par value $0.0001 per share (MPLT)
- Filing Manager
- Forbion Growth Opportunities Fund III Cooperatief U.A.
- Reporting Manager
- Forbion Growth Opportunities Fund III Cooperatief U.A.
- Symbol
- MPLT
- Shares outstanding
- 45,442,254 shares
- Disclosed Ownership
- 3,226,400 shares
- Ownership
- 7.1%
- Form type
- SCHEDULE 13G
- Filing time
- 17 Feb 2026, 08:31:49 UTC
- Date of event
- 31 Dec 2025
- SEC
- View on sec.gov
Quoteable Key Fact
"Forbion Growth Opportunities Fund III Cooperatief U.A. disclosed 7.1% ownership in MapLight Therapeutics, Inc. Voting Common Stock, par value $0.0001 per share (MPLT) on 31 Dec 2025."
What Changed
- No earlier schedule filing is available for direct comparison.
- Current filing was accepted on 17 Feb 2026, 08:31.
Why This Matters
- This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
- You can verify ownership claims directly against the original SEC filing.
Source Evidence
Backed by Schedule 13D/13G
See Original Filing
Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.
Reporting Managers (2)
| Name | Ownership | Shares Owned | sole voting power | shared voting power | Signature | Title | CIK |
|---|---|---|---|---|---|---|---|
| Forbion Growth Opportunities Fund III Cooperatief U.A. | 7.1% | 3,226,400 | 0 | 3,226,400 | /s/ G.J Mulder and /s/ M.A. van Osch | Directors of its Director | |
| Forbion Growth III Management B.V. | 7.1% | 3,226,400 | 0 | 3,226,400 | /s/ G.J Mulder and /s/ M.A. van Osch | Directors |